"AZ Delta is een ziekenhuis met campussen in Rumbeke, Roeselare, Menen en Torhout. In Menen en Torhout is een goed uitgebouwde basiszorg aanwezig. Voor meer gespecialiseerde behandelingen en ingrepen wordt doorverwezen naar de hoofdcampus in Rumbeke."

During the past decade, AZ Delta conducted 158 clinical trials. In the 10-year time frame, 158 clinical trials started and 39 clinical trials were completed, i.e. on average, 24.7% percent of trials that started reached the finish line to date. In the past 5 years, 100 clinical trials started and 35 clinical trials were completed. i.e. 35% of trials that started reached the finish line.

Out of the total clinical trials conducted in "AZ Delta" #1 sponsor was "Janssen Research & Development, LLC" with 15 trials, followed by "Universitaire Ziekenhuizen KU Leuven" with 14 trials sponsored, "Incyte Corporation" with 9 trials sponsored, "Bayer" with 8 trials sponsored and "University Hospital, Ghent" with 8 trials sponsored. Other sponsors include 136 different institutions and companies that sponsored additional 86 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "AZ Delta" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 7 trials as a collaborator, "AZ Delta" with 6 trials as a collaborator, "Eli Lilly and Company" with 5 trials as a collaborator, "University Hospital, Antwerp" with 4 trials as a collaborator and "AZ Sint-Jan AV" with 3 trials as a collaborator. Other collaborators include 107 different institutions and companies that were collaborators in the rest 95 trials.

According to Clinical.Site data, the most researched conditions in "AZ Delta" are "Atrial Fibrillation" (7 trials), "Chronic Obstructive Pulmonary Disease" (6 trials), "Crohn's Disease" (6 trials), "Acute Myeloid Leukemia" (5 trials) and "Colitis, Ulcerative" (5 trials). Many other conditions were trialed in "AZ Delta" in a lesser frequency.

Most popular intervention types in "AZ Delta" are "Drug" (140 trials), "Other" (23 trials), "Device" (22 trials), "Biological" (14 trials) and "Procedure" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (40 trials), "Rituximab" (5 trials), "Carboplatin" (4 trials), "Etrasimod" (4 trials) and "Pemetrexed" (4 trials). Other intervention names were less common.

The vast majority of trials in "AZ Delta" are 186 trials for "All" genders, 5 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are 100 active trials in "AZ Delta". 1 are not yet recruiting, 60 are recruiting, 38 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 73 completed trials in AZ Delta, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in AZ Delta, 7 "Phase 1" clinical trials were conducted, 53 "Phase 2" clinical trials and 71 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 17 trials, and there were also 19 trials that are defined as “Not Applicable".

AZ Delta has several departments that took part in Clinical trials: "AZ Delta vzw - Maag-darm-leverziekten" - 2 trials